Quantcast Mohamed Industry News
mohamed industry news By
mohamed industry news >> CANCER August 28, 2015 members login here
Monro Muffler Brake Breaks Below 200-Day Moving Average - Notable for MNRO
Minyanville - 8/24/2015
In trading on Monday, shares of Monro Muffler Brake, Inc. (MNRO) crossed below their 200 day moving average of $60.75, changing hands as low as $60.12 per share.. Related Stocks: GLOBAL X GURU SMALL
MNRO Makes Notable Cross Below Critical Moving Average Minyanville
Notable Two Hundred Day Moving Average Cross - TSN Minyanville
all 9908 news articles >>      Add Comment

BRIEF: SOCAR commissions well at offshore field [Trend News Agency, Baku, Azerbaijan]
Bloomberg - 15 Hours ago
Your requested update has been submitted Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If
Approach of Erika Puts Readiness Plans in Motion Bloomberg
Alzheimer's Association® Announces Purple Zone Bloomberg
all 11070 news articles >>      Add Comment

Chicago Researchers Roll Out Best Practices for Supportive Care of Cancer Patients
Biotechgate - 8/17/2015
CHICAGO , Aug. 17, 2015 /PRNewswire-USNewswire/ --  Northwestern Medicine ® and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University are working with key community stakeholders to
     Add Comment

GE Healthcare Secures FDA Clearance for Low Dose CT Lung Cancer Screening [Health
Pharmacy Choice - 8/20/2015
GE Healthcare reported it it the first company with a low dose computed tomography (CT) lung cancer screening option that is cleared by the U.S. FDA for lung cancer screening. According to a media
United States : GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Pharmacy Choice
GE Healthcare receives US FDA clearance for low dose CT lung cancer screening PharmaBiz
all 3 news articles >>      Add Comment

General Electric's GE Healthcare First to Receive FDA Clearance for Low Dose CT
Reuters UK - 8/17/2015
General Electric Co:Says it is the first company with a low dose computed tomography (CT) lung cancer screening option that is cleared by the U.S. FDA for lung cancer screening.Says both the U.S. Preventative
     Add Comment

Transparency Market Research Pvt Ltd: Rising Incidence of Cancer Boosts Global Proton
Bloomberg - 8/17/2015
The alarmingly rising incidence of cancer around the world, together with limited treatment facilities for the ailment, has impelled physicians to explore treatments beyond the conventional methods. Given
all 1 news articles >>      Add Comment

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity
Sys-Con India - 8/18/2015
NEW YORK, Aug. 18, 2015 /PRNewswire/ -- Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen
all 2 news articles >>      Add Comment

Pivotal Phase II study showed Roche's investigational immunotherapy atezolizumab
MDLinx - 8/18/2015
As you were browsing http://www.mdlinx.com something about your browser made us think you were a bot. There are a few reasons this might happen: You're a power user moving through this website with
     Add Comment

Pivotal Phase II Study Showed Genentech's Investigational Immunotherapy Atezolizumab
Pharmacy Choice - 8/18/2015
Release date- 16082015 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that in the large pivotal Phase II study, BIRCH, the investigational cancer immunotherapy
     Add Comment

The influence of Helicobacter pylori eradication on the expression and methylation
Journal of Digestive Diseases - 8/17/2015
Objective To investigate the effect of Helicobacter pylori ( H. pylori ) eradication on the expression level of the FHIT gene and its methylation status in the gastric mucosa of dyspeptic patients with
all 2 news articles >>      Add Comment

Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink?
Bone Marrow Transplantation - 8/17/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Bone Marrow Transplantation , (17 August 2015) | doi :10.1038/bmt.2015.179
     Add Comment

Canadian oncologist appointed by WHO to build breast, cervical cancer care programs
CBC - 8/17/2015
A Canadian oncologist has been appointed by the World Health Organization to help create guidelines and programs to provide earlier diagnosis and treatment of cancers that are killing more women in developing
     Add Comment

Comparison of dexmedetomidine with on-demand midazolam versus midazolam alone for
Journal of Digestive Diseases - 8/17/2015
Objective Endoscopic submucosal dissection (ESD) is commonly performed as a treatment for gastric neoplasms. However, sedation with midazolam (MDZ) often does not reach satisfactory sedation levels during
     Add Comment

Pancreatic Cancer Pipeline Review: H1 2015 - Reviews Key Players Involved in the
Individual.com - 8/17/2015
Research and Markets (http://www.researchandmarkets.com/research/7tnfhf/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer - Pipeline Review, H1 2015" report to their offering. Summary
     Add Comment

GlaxoSmithKline plc Deal Unlikely To Help Novartis AG Top Oncology Sales
Bidness Etc - 8/17/2015
Novartis AG (ADR) ( NYSE:NVS ) concluded its three-way asset swap transaction with GlaxoSmithKline plc. (ADR) ( NYSE:GSK ) in March 2015. Under the deal, Novartis acquired GSK’s cancer drug portfolio
     Add Comment

Champions Oncology Files Patents for Use of PDX Platform in Immune-Oncology
A.M. Best - 8/17/2015
     Add Comment

Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer
Angewandte Chemie - 8/17/2015
Abstract A novel cleavable amphiphilic peptide (CAP) was designed to be specifically responsive to fibroblast activation protein-a (FAP-a), a protease specifically expressed on the surface of cancer-associated
     Add Comment

Thousands sign donor register to help save Elsie, two
ITV.com - 8/17/2015
More than 5,000 people have registered as blood donors after an appeal to help save the life of a cancer-striken toddler. Two-year-old Elsie Kumar, who has Down's syndrome, was diagnosed with myeloid
all 1 news articles >>      Add Comment

R-Pharm US Acquires Breast Cancer Drug Ixempra From Bristol-Myers Squibb
RTTNews.com - 8/17/2015
R-Pharm US announced that it acquired breast cancer drug Ixempra (ixabepilone) from Bristol-Myers Squibb Co. (BMY). Financial terms were not disclosed. Ixempra is indicated as monotherapy or in combination
     Add Comment

Multicentre survey to explore current survival of patients with acute myeloid leukaemia
European Journal of Haematology - 8/17/2015
Abstract Background Acute myeloid leukaemia not responsive to first induction chemotherapy (PIF-AML) still remains a challenge, and there are only few recent epidemiological data regarding the outcome
     Add Comment

Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous
Histopathology - 8/17/2015
Aims Solitary fibrous tumour (SFT) harbours recurrent inv12(q13q13)-derived NAB2 – STAT 6 fusions, resulting in STAT6 nuclear expression. SFTs affecting the head and neck are rare, for which we reported
     Add Comment

Idaho Society of Clinical Oncology Partners with Seattle Cancer Care Alliance for
Pharmacy Choice - 8/17/2015
OWASSO, Okla., Aug. 17, 2015 /PRNewswire/ The Idaho Society of Clinical Oncology (ISCO) held its annual Board of Directors retreat in Sun Valley, ID on July 24-26, 2015. The focus for the retreat was
all 1 news articles >>      Add Comment

Chronic fatigue a long-term problem for testicular cancer survivors
MyInforms - 8/17/2015
at 5:15 PM · No Comments By Shreeya Nanda, Senior medwireNews Reporter A Norwegian population-based study reported in the Annals of Oncology has found a rise in the incidence of chronic fatigue a
     Add Comment

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53
Oncogene - 8/17/2015
ZNF322A encoding a classical Cys2His2 zinc finger transcription factor was previously revealed as a potential oncogene in lung cancer patients. However, the oncogenic role of ZNF322A and its underlying
     Add Comment

Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for
Oncogene - 8/17/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene , (17 August 2015) | doi :10.1038/onc.2015.309 L Fan , G Peng , N Sahgal
     Add Comment

Already a member? Sign in
Email Address:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.